Funder
NIMH
NIDA
Brain and Behavior Research Foundation
Reference450 articles.
1. Chemical psychoses: LAD and related drugs;Hollister,1968
2. Psychedelic drugs reconsidered;Grinspoon,1979
3. The use of the drug discrimination paradigm for studying hallucinogenic agents. A review;Glennon,1982
4. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists;Glennon;Eur J Pharmacol,1983
5. Arylalkylamine drugs of abuse: an overview of drug discrimination studies;Glennon;Pharmacol Biochem Behav,1999
Cited by
212 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation;European Journal of Pharmacology;2024-03
2. Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice;Pharmacology Biochemistry and Behavior;2024-02
3. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans;Phytochemistry;2024-02
4. Synthetic surprise as the foundation of the psychedelic experience;Neuroscience & Biobehavioral Reviews;2024-02
5. Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence;Psychopharmacology;2024-01-12